Trial Profile
Clinical protocol for a double-blind, randomized, active- controlled comparison study of the antihypertensive effect of eplerenone versus losartan in patients with mild to moderate hypertension.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2009
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; Losartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Apr 2008 New trial record.